NYSEMKT: ARMPArmata Pharmaceuticals Revenue
Armata Pharmaceuticals revenue was $4.21M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARMP annual revenue was $5.2M, with 14.2% growth year-over-year.
ARMP past revenue growth
How has ARMP's revenue growth performed historically?
Company
52.85%
Industry
150.01%
Market
20.37%
ARMP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARMP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARMP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
ARMP revenue history
Current Revenue
$4.2M
Current Earnings
-$25.7M
Current Profit Margin
-610.9%
Be the first to know when ARMP announces revenue.
ARMP Revenue History By Year
| ARMP Yearly Revenue | ARMP Revenue | ARMP Change | ARMP Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $5.17M | $645.00k | +14.24% |
| 2023-12-31 | $4.53M | -$979.00k | -17.77% |
| 2022-12-31 | $5.51M | $1.03M | +23.11% |
| 2021-12-31 | $4.47M | $3.65M | +443.62% |
| 2020-12-31 | $823.00k | N/A | N/A |
| 2019-12-31 | $0.00 | N/A | N/A |
| 2018-12-31 | $0.00 | -$115.00k | -100.00% |
| 2017-12-31 | $115.00k | -$145.00k | -55.77% |
| 2016-12-31 | $260.00k | -$215.00k | -45.26% |
| 2015-12-31 | $475.00k | $66.00k | +16.14% |
| 2014-12-31 | $409.00k | $328.00k | +404.94% |
| 2013-12-31 | $81.00k | -$583.00k | -87.80% |
| 2012-12-31 | $664.00k | $544.00k | +453.33% |
| 2011-12-31 | $120.00k | N/A | N/A |
| 2008-12-31 | $8.72M | -$1.61M | -15.62% |
| 2007-12-31 | $10.33M | $468.00k | +4.74% |
| 2006-12-31 | $9.86M | $2.99M | +43.50% |
| 2005-12-31 | $6.87M | -$2.78M | -28.78% |
| 2004-12-31 | $9.65M | -$4.42M | -31.41% |
| 2003-12-31 | $14.07M | -$5.26M | -27.21% |
| 2002-12-31 | $19.33M | $453.00k | +2.40% |
| 2001-12-31 | $18.88M | $7.48M | +65.57% |
| 2000-12-31 | $11.40M | $4.56M | +66.52% |
| 1999-12-31 | $6.85M | -$662.25k | -8.82% |
| 1998-12-31 | $7.51M | $6.18M | +465.71% |
| 1997-12-31 | $1.33M | -$926.59k | -41.11% |
| 1996-12-31 | $2.25M | $1.41M | +167.57% |
| 1995-12-31 | $842.46k | N/A | N/A |
| 1994-12-31 | N/A | N/A | N/A |
Armata Pharmaceuticals Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.